Alamar Biosciences ALMR
Alamar Biosciences, Inc. · Nasdaq · Laboratory Analytical Instruments
$34.30+7.42%close on Oct. 28, 2026 · volume 1.1M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 26, 2026 | Qiming Corporate GP VI Ltd. with Qiming Managing Directors Fund VI L.P., Qiming Venture Partners VI L.P., Qiming GP VIII LLC, Qiming Venture Partners VIII Investments LLC, Qiming GP VIII-HC LLC, Qiming Venture Partners VIII-HC L.P. 10% owner · indirect | Sold | 132,524 | $30.52 $30.52-$31.07 | $4.04 million |
| Oct. 23, 2026 | Qiming Corporate GP VI Ltd. with Qiming Managing Directors Fund VI L.P., Qiming Venture Partners VI L.P., Qiming GP VIII LLC, Qiming Venture Partners VIII Investments LLC, Qiming GP VIII-HC LLC, Qiming Venture Partners VIII-HC L.P. 10% owner · indirect | Sold | 147,934 | $30.59 $29.35-$30.85 | $4.53 million |
| Oct. 22, 2026 | Qiming Corporate GP VI Ltd. with Qiming Managing Directors Fund VI L.P., Qiming Venture Partners VI L.P., Qiming GP VIII LLC, Qiming Venture Partners VIII Investments LLC, Qiming GP VIII-HC LLC, Qiming Venture Partners VIII-HC L.P. 10% owner · indirect | Sold | 133,811 | $29.33 $29.00-$30.81 | $3.92 million |
| Oct. 21, 2026 | Qiming Corporate GP VI Ltd. with Qiming Managing Directors Fund VI L.P., Qiming Venture Partners VI L.P., Qiming GP VIII LLC, Qiming Venture Partners VIII Investments LLC, Qiming GP VIII-HC LLC, Qiming Venture Partners VIII-HC L.P. 10% owner · indirect | Sold | 208,815 | $30.31 $29.01-$30.79 | $6.33 million |
| Oct. 20, 2026 | Qiming Corporate GP VI Ltd. with Qiming Managing Directors Fund VI L.P., Qiming Venture Partners VI L.P., Qiming GP VIII LLC, Qiming Venture Partners VIII Investments LLC, Qiming GP VIII-HC LLC, Qiming Venture Partners VIII-HC L.P. 10% owner · indirect | Sold | 142,004 | $27.89 $26.63-$28.44 | $3.96 million |
| Oct. 19, 2026 | Qiming Corporate GP VI Ltd. with Qiming Managing Directors Fund VI L.P., Qiming Venture Partners VI L.P., Qiming GP VIII LLC, Qiming Venture Partners VIII Investments LLC, Qiming GP VIII-HC LLC, Qiming Venture Partners VIII-HC L.P. 10% owner · indirect | Sold | 75,508 | $26.34 | $1.99 million |
| Oct. 16, 2026 | Qiming Corporate GP VI Ltd. with Qiming Managing Directors Fund VI L.P., Qiming Venture Partners VI L.P., Qiming GP VIII LLC, Qiming Venture Partners VIII Investments LLC, Qiming GP VIII-HC LLC, Qiming Venture Partners VIII-HC L.P. 10% owner · indirect | Sold | 136 | $27.02 | $3,675 |
| Oct. 15, 2026 | Qiming Corporate GP VI Ltd. with Qiming Managing Directors Fund VI L.P., Qiming Venture Partners VI L.P., Qiming GP VIII LLC, Qiming Venture Partners VIII Investments LLC, Qiming GP VIII-HC LLC, Qiming Venture Partners VIII-HC L.P. 10% owner · indirect | Sold | 173,537 | $27.73 $27.73-$28.26 | $4.81 million |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 11 →Departure/appointment of directors or officers